Skip to main content
The Global Fund / Le Fonds mondial
Country Resources
Applying for Funding (GC8)
Search
Français
Search
Home
About Us
▶
About the Global Fund
Staff & Organization
Strategy & Framework
▶
Strategy (2023-2028)
The Global Fund's Monitoring and Evaluation Framework
Structures & Governance
▶
Governance & Policies
Board
Country Coordinating Mechanisms
Independent Evaluation & Learning
Local Fund Agents
Office of the Inspector General
Technical Review Panel
Our Partnership
▶
Civil Society
Friends of the Fund
Government & Public Donors
Implementing Partners
Private Sector & Philanthropy
Technical & Development Partners
Topics
▶
Diseases
HIV/AIDS
Tuberculosis
Malaria
Health Systems
Resilient & Sustainable Systems for Health
Antimicrobial Resistance
Community Health Workers
Digital Health
Laboratory Systems Strengthening
Community Responses & Systems
Cross-cutting
Health and Climate
Human Rights
Gender Equality
Global Health Security
Key Populations
Protection from Sexual Exploitation, Abuse and Harassment
Funding & Replenishment
▶
Funding & Finance
▶
How We Fund Our Grants
Who We Fund
Sustainability, Transition & Co-Financing
Resource Mobilization & Replenishment
▶
How We Raise Funds
Innovative Finance
Blended Financing
Debt Swaps (Debt2Health)
What is Replenishment
Eighth Replenishment
News & Media
▶
Latest
News Releases
Updates
Opinion
Stories
For Press
Newsroom
Digital Media Library
Multimedia
Video
Photo Galleries
Publications & Results
▶
Reports
Results Report
Donor Reports
Impact Reports
Thematic Reports
Partnership Reports
Other
Overviews
Resources & Data
▶
Data & Tools
Data Explorer
Data Service
Subsites
Country Resources
Sourcing & Management of Health Products
Contact & Engagement
▶
Work with us
Business & Consultancy Opportunities
Careers
Join us
Events
Contact Us
Lenacapavir
Home
Related Links
Lenacapavir
Print
Link copied!
Facebook
X
LinkedIn
Markdown version of the page
5 items since 2024
Often appears with
HIV and AIDS
United States
News
2
items
News
09 July 2025
Global Fund Secures Access to Breakthrough HIV Prevention Drug Lenacapavir for Low- and Middle-Income Countries
News
17 December 2024
Global Fund, PEPFAR Announce Coordinated Effort to Reach 2 Million People with Lenacapavir for PrEP to Significantly Reduce Global HIV Infections
Update
2
items
Update
14 April 2026
Global Fund and U.S. Expand Commitment to Long-Acting HIV Prevention as Country Rollout of Lenacapavir Accelerates
Update
04 September 2025
The Global Fund Welcomes Commitment by the United States to Expand Access to Lenacapavir
Story
1
item
Story
08 April 2026
In Eswatini, an HIV Breakthrough Delivered
